Akoya Biosciences Inc (AKYA)
2.85
-0.05
(-1.72%)
USD |
NASDAQ |
May 17, 16:00
2.85
0.00 (0.00%)
After-Hours: 20:00
Akoya Biosciences Research and Development Expense (Quarterly): 5.554M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 5.554M |
December 31, 2023 | 4.67M |
September 30, 2023 | 5.173M |
June 30, 2023 | 6.273M |
March 31, 2023 | 6.378M |
December 31, 2022 | 6.433M |
September 30, 2022 | 5.466M |
June 30, 2022 | 5.598M |
March 31, 2022 | 5.714M |
Date | Value |
---|---|
December 31, 2021 | 5.563M |
September 30, 2021 | 3.999M |
June 30, 2021 | 2.947M |
March 31, 2021 | 3.192M |
December 31, 2020 | 2.532M |
September 30, 2020 | 2.279M |
June 30, 2020 | 2.42M |
March 31, 2020 | 2.372M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
2.279M
Minimum
Sep 2020
6.433M
Maximum
Dec 2022
4.504M
Average
5.173M
Median
Sep 2023
Research and Development Expense (Quarterly) Benchmarks
Azenta Inc | 8.707M |
Harvard Bioscience Inc | 2.885M |
Standard BioTools Inc | 15.98M |
Bionano Genomics Inc | 9.779M |
Singular Genomics Systems Inc | 11.49M |